Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden. | J Immunother Cancer | 2023 | 36792124 | PubTator, text mining | PubMed |
| Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma. | Cancer Res | 2023 | 36779841 | PubTator, text mining | PubMed |
| Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells. | Cancers (Basel) | 2023 | 36765677 | PubTator, text mining | PubMed |
| EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 36760869 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer. | Int J Gen Med | 2023 | 36756390 | PubTator, text mining | PubMed |
| Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry. | Cancer Metastasis Rev | 2023 | 36754910 | PubTator, text mining | PubMed |
| MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells. | J Immunother Cancer | 2023 | 36754452 | PubTator, text mining | PubMed |
| Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET. | Cell Rep Med | 2023 | 36754052 | PubTator, text mining | PubMed |
| Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T. | Mol Cancer | 2023 | 36750830 | PubTator, text mining | PubMed |
| SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis. | J Clin Invest | 2023 | 36749634 | PubTator, text mining | PubMed |
| Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer. | Front Endocrinol (Lausanne) | 2023 | 36742380 | PubTator, text mining | PubMed |
| Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer. | Front Immunol | 2023 | 36742322 | PubTator, text mining | PubMed |
| Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis. | Front Immunol | 2023 | 36733486 | PubTator, text mining | PubMed |
| Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma. | BMC Cancer | 2023 | 36717792 | PubTator, text mining | PubMed |
| Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis. | Cancer Med | 2023 | 36708070 | PubTator, text mining | PubMed |
| A ferroptosis-related prognostic model with excellent clinical performance based on the exploration of the mechanism of oral squamous cell carcinoma progression. | Sci Rep | 2023 | 36702843 | PubTator, text mining | PubMed |
| Profiling Glycosylphosphatidylinositol (GPI)-Interacting Proteins in the Cell Membrane Using a Bifunctional GPI Analogue as the Probe. | J Proteome Res | 2023 | 36700487 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis. | Cell Death Discov | 2023 | 36681667 | PubTator, text mining | PubMed |
| Mining TCGA Database for Genes with Prognostic Value in Breast Cancer. | Int J Mol Sci | 2023 | 36675137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=27